Interactions between Microbiome and DME (MICBIO)
|
Bacteria: Bacteroidetes |
Alistipes indistinctus (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Norethindrone acetate |
Click to Show/Hide the Detail |
Drug ID |
DR1750
Drug Info
|
Interaction Mechanism |
Human Aldo-keto reductase 1D1 (AKR1D1) and Alistipes indistinctus co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Bacteroides caccae (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Norethindrone acetate |
Click to Show/Hide the Detail |
Drug ID |
DR1750
Drug Info
|
Interaction Mechanism |
Human Aldo-keto reductase 1D1 (AKR1D1) and Bacteroides caccae co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Bacteroides cellulosilyticus (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Norethindrone acetate |
Click to Show/Hide the Detail |
Drug ID |
DR1750
Drug Info
|
Interaction Mechanism |
Human Aldo-keto reductase 1D1 (AKR1D1) and Bacteroides cellulosilyticus co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Bacteroides coprophilus (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Norethindrone acetate |
Click to Show/Hide the Detail |
Drug ID |
DR1750
Drug Info
|
Interaction Mechanism |
Human Aldo-keto reductase 1D1 (AKR1D1) and Bacteroides coprophilus co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Bacteroides dorei (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Norethindrone acetate |
Click to Show/Hide the Detail |
Drug ID |
DR1750
Drug Info
|
Interaction Mechanism |
Human Aldo-keto reductase 1D1 (AKR1D1) and Bacteroides dorei co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Bacteroides eggerthii (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Norethindrone acetate |
Click to Show/Hide the Detail |
Drug ID |
DR1750
Drug Info
|
Interaction Mechanism |
Human Aldo-keto reductase 1D1 (AKR1D1) and Bacteroides eggerthii co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Bacteroides finegoldii (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Norethindrone acetate |
Click to Show/Hide the Detail |
Drug ID |
DR1750
Drug Info
|
Interaction Mechanism |
Human Aldo-keto reductase 1D1 (AKR1D1) and Bacteroides finegoldii co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Bacteroides fragilis (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Norethindrone acetate |
Click to Show/Hide the Detail |
Drug ID |
DR1750
Drug Info
|
Interaction Mechanism |
Human Aldo-keto reductase 1D1 (AKR1D1) and Bacteroides fragilis co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Bacteroides intestinalis (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Norethindrone acetate |
Click to Show/Hide the Detail |
Drug ID |
DR1750
Drug Info
|
Interaction Mechanism |
Human Aldo-keto reductase 1D1 (AKR1D1) and Bacteroides intestinalis co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Bacteroides ovatus (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Norethindrone acetate |
Click to Show/Hide the Detail |
Drug ID |
DR1750
Drug Info
|
Interaction Mechanism |
Human Aldo-keto reductase 1D1 (AKR1D1) and Bacteroides ovatus co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Bacteroides sartorii (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Norethindrone acetate |
Click to Show/Hide the Detail |
Drug ID |
DR1750
Drug Info
|
Interaction Mechanism |
Human Aldo-keto reductase 1D1 (AKR1D1) and Bacteroides sartorii co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Bacteroides stercoris (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Norethindrone acetate |
Click to Show/Hide the Detail |
Drug ID |
DR1750
Drug Info
|
Interaction Mechanism |
Human Aldo-keto reductase 1D1 (AKR1D1) and Bacteroides stercoris co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Bacteroides thetaiotaomicron (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Norethindrone acetate |
Click to Show/Hide the Detail |
Drug ID |
DR1750
Drug Info
|
Interaction Mechanism |
Human Aldo-keto reductase 1D1 (AKR1D1) and Bacteroides thetaiotaomicron co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Bacteroides uniformis (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Norethindrone acetate |
Click to Show/Hide the Detail |
Drug ID |
DR1750
Drug Info
|
Interaction Mechanism |
Human Aldo-keto reductase 1D1 (AKR1D1) and Bacteroides uniformis co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Bacteroides vulgatus (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Norethindrone acetate |
Click to Show/Hide the Detail |
Drug ID |
DR1750
Drug Info
|
Interaction Mechanism |
Human Aldo-keto reductase 1D1 (AKR1D1) and Bacteroides vulgatus co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Bacteroides xylanisolvens (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Norethindrone acetate |
Click to Show/Hide the Detail |
Drug ID |
DR1750
Drug Info
|
Interaction Mechanism |
Human Aldo-keto reductase 1D1 (AKR1D1) and Bacteroides xylanisolvens co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Odoribacter splanchnicus (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Norethindrone acetate |
Click to Show/Hide the Detail |
Drug ID |
DR1750
Drug Info
|
Interaction Mechanism |
Human Aldo-keto reductase 1D1 (AKR1D1) and Odoribacter splanchnicus co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Parabacteroides johnsonii (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Norethindrone acetate |
Click to Show/Hide the Detail |
Drug ID |
DR1750
Drug Info
|
Interaction Mechanism |
Human Aldo-keto reductase 1D1 (AKR1D1) and Parabacteroides johnsonii co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Parabacteroides merdae (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Norethindrone acetate |
Click to Show/Hide the Detail |
Drug ID |
DR1750
Drug Info
|
Interaction Mechanism |
Human Aldo-keto reductase 1D1 (AKR1D1) and Parabacteroides merdae co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Prevotella copri (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Norethindrone acetate |
Click to Show/Hide the Detail |
Drug ID |
DR1750
Drug Info
|
Interaction Mechanism |
Human Aldo-keto reductase 1D1 (AKR1D1) and Prevotella copri co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Bacteria: Firmicutes |
Blautia hansenii (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Norethindrone acetate |
Click to Show/Hide the Detail |
Drug ID |
DR1750
Drug Info
|
Interaction Mechanism |
Human Aldo-keto reductase 1D1 (AKR1D1) and Blautia hansenii co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Clostridium botulinum (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Norethindrone acetate |
Click to Show/Hide the Detail |
Drug ID |
DR1750
Drug Info
|
Interaction Mechanism |
Human Aldo-keto reductase 1D1 (AKR1D1) and Clostridium botulinum co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Holdemanella biformis (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Norethindrone acetate |
Click to Show/Hide the Detail |
Drug ID |
DR1750
Drug Info
|
Interaction Mechanism |
Human Aldo-keto reductase 1D1 (AKR1D1) and Holdemanella biformis co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Hungatella hathewayi (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Norethindrone acetate |
Click to Show/Hide the Detail |
Drug ID |
DR1750
Drug Info
|
Interaction Mechanism |
Human Aldo-keto reductase 1D1 (AKR1D1) and Hungatella hathewayi co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Ruminococcus gnavus (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Norethindrone acetate |
Click to Show/Hide the Detail |
Drug ID |
DR1750
Drug Info
|
Interaction Mechanism |
Human Aldo-keto reductase 1D1 (AKR1D1) and Ruminococcus gnavus co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Ruminococcus torques (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Norethindrone acetate |
Click to Show/Hide the Detail |
Drug ID |
DR1750
Drug Info
|
Interaction Mechanism |
Human Aldo-keto reductase 1D1 (AKR1D1) and Ruminococcus torques co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Bacteria: Proteobacteria |
Escherichia coli (enterobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Norethindrone acetate |
Click to Show/Hide the Detail |
Drug ID |
DR1750
Drug Info
|
Interaction Mechanism |
Human Aldo-keto reductase 1D1 (AKR1D1) and Escherichia coli co-metabolize the drug Norethindrone acetate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
|
|
|
|
|
|